CD34 and Fibroadenoma: CD34 has been considered a vital marker for DFSP and can be used to differentiate DFSP of the breast from CD34-negative fibrous soft tissue tumors, such as dermatofibromas, breast fibroadenomas, and fibrosarcomas.